“The healthcare reform law has had a ‘devastating’ impact on insurance agents and brokers, according to a new survey from the National Association of Insurance and Financial Advisers. The group said 75 percent of its members have seen a drop in their commissions since the new law capped the amount of money that insurers can spend on administrative expenses and profits.”Details
“The real problem, according to a new survey from the American College of Emergency Physicians, isn’t caused by people who don’t have insurance — it’s caused by people who do, but still can’t find a doctor to treat them.
A full 97 percent of ER doctors who responded to the ACEP survey said they treated patients ‘daily’ who have Medicaid (the federal-state health plan for the low-income), but who can’t find a doctors who will accept their insurance.”
“The health reform bill signed into law last year is expected to significantly increase the number of Americans with health insurance or participating in the Medicaid program. Meanwhile, an aging population will increase participation in Medicare. This means a greater demand for physician services.
But at the same, the bill may drive physicians out of practice.”
“For years, doctors have urged patients over the age of 50 to get colonoscopies to check for colorectal cancer, which kills 50,000 Americans a year. Their efforts were boosted last year by the federal health care law, which requires that key preventive services, including colonoscopies, be provided to patients at no out-of-pocket cost.
But there’s a wrinkle in the highly touted benefit. If doctors find and remove a polyp, which can be cancerous, some private insurers and Medicare hit the patient with a surprise: charges that could run several hundred dollars.”
“So, I’d like the advocates of IPAB to tell me two things: (1) Can they formulate an objective way for the government to determine how much Lucentis should cost? (2) Why shouldn’t individuals get to decide for themselves how much they would be willing to pay to see out of both of their eyes, instead of just one?”Details
“This month, the federal government announced that unemployment has barely budged in the last two months. More than 13 million people remain out of work. Yet several self-proclaimed ‘consumer advocates’ are leading the charge in support of a provision of the federal health care law that could eliminate jobs throughout the country.”Details
“First, the penalty for not buying health insurance is not a tax. Even if the penalty were a tax, it would fail the constitutional requirements for income, excise, or direct taxes. Second, the power to regulate interstate commerce extends only to economic activities; it does not permit Congress to compel such activities in order to regulate them. Third, the mandate is not necessary; indeed, it is merely a means to circumvent problems that would not exist if not for PPACA itself.”Details
“The sugar-coated rhetoric from HHS cannot disguise the bad medicine in this part of the Affordable Care Act, which intends to bureaucratically cut as much as $960 million in Medicare spending over three years. This Obamacare prescription threatens patients, the physicians who care for them, and the common good.”Details
“PhRMA saw the health care overhaul as a chance to advance its long-term interests and played along. But funny enough, it now seems that the White House is not all that interested in holding up its end of the bargain. President Obama’s recent speech on the debt included proposals that would violate the agreement.”Details
“In 2012, Obamacare will create the ‘Value-Based Purchasing Program’ in Medicare. Using a pay-for-performance scheme, the program will reimburse hospitals and other health care providers at different rates based on how they score on performance measures chosen by the Secretary of Health and Human Services. Proponents of pay-for-performance see it as a way to use financial incentives to streamline and improve the quality of health care while attempting to reduce costs. But the fact is that standardization of the practice of medicine costs patients and physicians tremendously, and evidence shows it does very little to improve health outcomes.”Details